Qutenza

Acorda acquires medications

Acorda acquires medications

By

Acorda Therapeutics Inc. has acquired two assets from NeurogesX Inc. The company paid $8 million to acquire development and commercialization rights for Qutenza® and NP-1998 in the US, Canada, and Latin America.